4Haffner SM, Miettinen H. Insulin resistance implications for type II diabetes mellitus and coronary heart disease[J]. Am J Med, 1997,193:152-162.
5A.Gokcel, M.Aydin, F.Yalcin, et al. Silent coronary artery disease in patients with type 2 diabetes mellitus[J]. Acta Diabetol, 2003,40:176-180.
6Carmine Gazzaruso, Adriana Garzaniti, Stefano Giordanetti, et al. Silent coronary artery disease in type 2 diabetes mellitus:the role of Lipoprotein(a), homocysteine and apo(a) polymorphism[J]. Cardiovascular Diabetology, 2002, 1:5.
7Farzad Hadaegh, Nooshin Fahimfar, Davood Khalili, et al. New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a middle east population[J]. Cardiovascular Diabetology, 2010,9:84.
8Toshio Murase, Minoru Okubo, Michiyo Amemiya-Kudo, et al. Impact of elevated serum lipoprotein(a)concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus[J]. Metabolism Clinical and Experimental, 2008,57:791-795.
9Grundy SM, Benjamin [J, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association[J]. Circulation, 1999,100: 1134-1146.
